Cyclic α-Quaternary α-Amino Acid Enantiomers
= 37.7 Hz), 144.89, 139.62, 129.80, 127.32, 125.48, 122.59, 115.53
Compound (S)-8b: Compound (S)-7b (62.00 mg, 0.17 mmol) was
(q, J = 128.0 Hz), 69.77, 62.52, 35.41, 31.04, 13.92 ppm. HRMS: transformed into (S)-8b (42.16 mg, 0.17 mmol, 99%) as described
calcd. for C14H14F3NO3Na [M + Na]+ 324.0818; found 324.0807.
above. [α]2D4 = +98.3 (c = 0.58, MeOH).
Compound (S)-7a: [α]2D4 = +146.5 (c = 1.0, CHCl3). 1H NMR
(500 MHz, CDCl3): δ = 7.36–7.31 (m, 2 H), 7.26–7.24 (m, 2 H),
4.14 (t, J = 6.5 Hz, 2 H), 3.18 (t, J = 7.3 Hz, 2 H), 3.00 (m, 1 H),
2.54 (m, 1 H), 1.55 (m, 2 H), 1.23 (m, 2 H), 0.85 (t, J = 7.3 Hz, 3
H) ppm. HRMS: calcd. for C16H18F3NO3 [M + Na]+ 352.1131;
found 352.1123.
Preparative-Scale Enzymatic Kinetic Resolution of rac-1c: As de-
scribed above, rac-1c (0.32 g, 1.44 mmol) was resolved, affording
solid products (R)-6c (Rf = 0.19; 0.21 g, 0.67 mmol, 47%, ee 96%)
and (S)-7c (Rf = 0.29; 0.25 g, 0.71 mmol, 49%, ee 99%).
Compound (R)-6c: M.p. 78–79 °C; [α]2D4 = –93.2 (c = 1.0, CHCl3).
1H NMR (500 MHz, CDCl3): δ = 7.18 (dd, J = 8.5, 5.0 Hz, 1 H),
6.99 (d, J = 8.5 Hz, 1 H), 6.93 (t, J = 8.5 Hz, 1 H), 4.20 (m, 2 H),
3.17 (m, 2 H), 2.98 (m, 1 H), 2.58 (m, 1 H), 1.21 (t, J = 7.3 Hz, 3
H) ppm. 13C NMR (126 MHz, CDCl3): δ = 171.19, 163.94 (d, J =
248.2 Hz), 156.03 (q, J = 37.8 Hz), 147.43 (d, J = 8.8 Hz), 135.31
(d, J = 2.5 Hz), 123.97 (d, J = 10.1 Hz), 115.47 (q, J = 288.5 Hz),
114.63 (d, J = 23.9 Hz), 112.44 (d, J = 22.7 Hz), 69.06, 62.70, 35.74,
30.99, 13.89 ppm. HRMS: calcd. for C14H13F4NO3Na [M + Na]+
342.0724; found 342.0709.
Compound (R)-8a: Hydrolysis of (R)-6a (50.0 mg, 0.17 mmol) in
aqueous HCl (6 m) produced (R)-8a (36.28 mg, 0.17 mmol, 99%);
m.p. 230 °C (dec.). [α]2D4 = –100.1 (c = 0.18, MeOH). 1H NMR
(500 MHz, CD3OD): δ = 7.46–7.40 (m, 3 H), 7.34 (t, J = 7.0 Hz,
1 H), 3.24 (t, J = 7.0 Hz, 2 H), 2.92 (m, 1 H), 2.35 (m, 1 H) ppm.
13C NMR (126 MHz, CD3OD): δ = 171.57, 144.67, 138.19, 130.22,
127.25, 125.33, 122.98, 68.27, 34.72, 30.20 ppm. HRMS: calcd. for
C10H12NO2 [M – Cl]+ 178.0863; found 178.0843.
Compound (S)-8a: Compound (S)-7a (60.0 mg, 0.18 mmol) was
Compound (S)-7c: [α]2D4 = +89.2 (c = 1.0, CHCl3). 1H NMR
(500 MHz, CDCl3): δ = 7.18 (dd, J = 8.5, 5.0 Hz, 1 H), 6.99 (d, J
= 8.5 Hz, 1 H), 6.93 (t, J = 8.5 Hz, 1 H), 4.15 (t, J = 6.5 Hz, 2 H),
3.17 (m, 2 H), 2.96 (m, 1 H), 2.58 (m, 1 H), 1.55 (m, 2 H), 1.24
(m, 2 H), 0.86 (t, J = 7.5 Hz, 3 H) ppm. 13C NMR (126 MHz,
CDCl3): δ = 171.33, 163.92 (d, J = 248.2 Hz), 156.00 (d, J =
37.8 Hz), 147.35 (d, J = 8.8 Hz), 135.37 (d, J = 2.5 Hz), 123.92 (d,
J = 8.8 Hz), 115.62 (q, J = 289.8 Hz), 114.55 (d, J = 23.9 Hz),
112.41 (d, J = 22.7 Hz), 69.09, 66.45, 35.70, 30.98, 30.31, 18.85,
transformed into (S)-8a (38.41 mg, 0.18 mmol, 99%). [α]2D4
+105.8 (c = 0.18, MeOH).
=
Determination of Absolute Configuration: Hydrochloride salt (S)-8a
(19.22 mg, 0.09 mmol) was treated with 2-propanol/propylene ox-
ide (2.5/0.2 mL) at room temperature for 3 h. The white precipitate
(S)-9 was filtered off and dried (10.62 mg, 0.06 mmol, 65%). [α]2D4
= +107.1 (c = 0.96, MeOH) [ref. for (S)-9[15] [α]2D4 = +103.7 (c =
0.96, MeOH)]; m.p. 248–249 °C (ref.[15] 247 °C). 1H NMR
(500 MHz, CD3OD): δ = 7.47 (d, J = 8.0 Hz, 1 H), 7.35 (d, J =
4.0 Hz, 2 H), 7.31–7.23 (m, 1 H), 3.17 (m, 2 H), 2.92 (m, 1 H), 2.22
(m, 1 H) ppm. 13C NMR (126 MHz, CD3OD): δ = 174.33, 144.64,
141.18, 129.10, 126.71, 124.77, 123.16, 70.02, 34.70, 30.36 ppm.
HRMS: calcd. for C10H11NO2 [M + Na]+ 200.0682; found
200.0673.
13.46 ppm. HRMS: calcd. for C16H17F4NO3Na [M
371.1115; found 371.1101.
+
Na]+
Compound (R)-8c: The hydrolysis of (R)-6c (57.4 mg, 0.18 mmol)
in aqueous HCl (6 m) produced (R)-8c (41.67 mg, 0.18 mmol,
1
99%); m.p. 249–250 °C. [α]2D4 = –94.8 (c = 0.57, MeOH). H NMR
(500 MHz, CD3OD): δ = 7.47 (dd, J = 8.5, 4.5 Hz, 1 H), 7.16–7.07
(m, 2 H), 3.24 (t, J = 7.5 Hz, 2 H), 2.94 (m, 1 H), 2.41 (m, 1
H) ppm. 13C NMR (126 MHz, CD3OD): δ = 171.31, 164.41 (d, J
= 248.2 Hz), 147.79 (d, J = 8.8 Hz), 134.17, 124.90 (d, J = 10.1 Hz),
114.44 (d, J = 23.9 Hz), 112.17 (d, J = 22.7 Hz), 67.54, 35.17,
30.18 ppm. HRMS: calcd. for C10H11FNO2 [M – Cl]+ 196.0768;
found 196.0745.
Preparative-Scale Enzymatic Kinetic Resolution of rac-1b: As above,
rac-1b (0.30 g, 1.25 mmol) was resolved, affording solid products
(R)-6b (Rf = 0.11; 0.20 g, 0.61 mmol, 49%, ee 96%) and (S)-7b (Rf
= 0.19; 0.22 g, 0.60 mmol, 48%, ee 99%).
Compound (R)-6b: m.p. 72–73 °C. [α]2D4 = –81.6 (c = 1.0, CHCl3).
1H NMR (500 MHz, CDCl3): δ = 7.30 (s, 1 H), 7.21 (d, J = 8.0 Hz,
1 H), 7.14 (d, J = 8.0 Hz, 1 H), 4.21 (m, 2 H), 3.18 (m, 2 H), 2.93
(m, 1 H), 2.59 (m, 1 H), 1.21 (t, J = 7.3 Hz, 3 H) ppm. 13C NMR
(126 MHz, CDCl3): δ = 171.16, 155.97 (d, J = 37.8 Hz), 146.81,
138.19, 135.71, 127.65, 125.71, 123.63, 115.44 (d, J = 289.8 Hz),
69.20, 62.83, 35.48, 30.91, 13.89 ppm. HRMS: calcd. for
C14H11ClF3NO3Na [M + Na]+ 358.0428; found 358.0421.
Compound (S)-7b: [α]2D4 = +66.5 (c = 1.0, CHCl3). 1H NMR
(500 MHz, CDCl3): δ = 7.29 (s, 1 H), 7.20 (d, J = 8.0 Hz, 1 H),
7.13 (d, J = 8.0 Hz, 1 H), 4.14 (m, 2 H), 3.17 (m, 2 H), 2.92 (m, 1
H), 2.57 (m, 1 H), 1.54 (m, 2 H), 1.24 (m, 2 H), 0.86 (t, J = 7.5 Hz,
3 H) ppm. 13C NMR (126 MHz, CDCl3): δ = 171.24, 155.97 (q, J
= 28.4 Hz), 146.73, 138.25, 135.64, 127.57, 125.65, 123.65, 115.45
(q, J = 216.72 Hz), 69.24, 66.55, 35.47, 30.88, 30.30, 18.86,
13.46 ppm. HRMS: calcd. for C16H16ClF3NO3Na [M + Na]+
386.0746; found 386.0732.
Compound (S)-8c: Compound (S)-7c (50.00 mg, 0.14 mmol) was
transformed into (S)-8c (32.41 mg, 0.14 mmol, 99%). [α]2D4 = +98.5
(c = 0.57, MeOH).
Preparative-Scale Enzymatic Kinetic Resolution of rac-1d: Per-
formed as described above except that the reaction was carried out
at 47 °C for 144 h, rac-1d (0.30 g, 1.37 mmol) was resolved, afford-
ing solid product (R)-6d (Rf = 0.17; 0.21 g, 0.66 mmol, 48%, ee
95%) and oily product (S)-7d (Rf = 0.25; 0.22 g, 0.65 mmol, 47%,
ee 99%).
Compound (R)-6d: M.p. 69–70 °C. [α]2D4 = –60.3 (c = 0.56, CHCl3).
1H NMR (500 MHz, CDCl3): δ = 7.26–7.16 (m, 4 H), 4.22 (m, 2
H), 2.93 (m, 1 H), 2.84 (m, 1 H), 2.59 (m, 1 H), 2.38 (m, 1 H), 2.10
(m, 1 H), 1.89 (m, 1 H), 1.22 (t, J = 7.0 Hz, 3 H) ppm. 13C NMR
(126 MHz, CDCl3): δ = 171.96, 155.36 (d, J = 36.5 Hz), 138.83,
132.89, 129.79, 128.62, 126.98, 125.93, 115.53 (q, J = 289.8 Hz),
62.69, 61.38, 30.83, 29.13, 20.02, 13.90 ppm. HRMS: calcd. for
C15H16F3NO3Na [M + Na]+ 338.0974; found 338.0984.
Compound (R)-8b: The hydrolysis of (R)-6b (60.0 mg, 0.18 mmol)
in aqueous HCl (6 m) produced (R)-8b (44.64 mg, 0.18 mmol,
99%); m.p. 265 °C (dec.). [α]2D4 = –94.9 (c = 0.58, MeOH). 1H NMR
(500 MHz, CD3OD): δ = 7.44–7.35 (m, 3 H), 3.24 (t, J = 7.0 Hz, Compound (S)-7d: [α]2D4 = +73.9 (c = 1.00, CHCl3). 1H NMR
2 H), 2.94 (m, 1 H), 2.38 (m, 1 H) ppm. 13C NMR (126 MHz,
CD3OD): δ = 171.13, 147.07, 136.98, 136.24, 127.51, 125.52, (t, J = 7.5 Hz, 2 H), 4.16 (m, 2 H), 2.95 (m, 1 H), 2.82 (m, 1 H),
(500 MHz, CDCl3): δ = 7.43 (br. s, 1 H), 7.26–7.22 (m, 2 H), 7.17
124.45, 67.65, 34.94, 30.07 ppm. HRMS: calcd. for C10H11ClNO2
2.59 (m, 1 H), 2.36 (m, 1 H), 2.10 (m, 1 H), 1.90 (m, 1 H), 1.56
[M – Cl]+ 212.0473; found 212.0464.
(m, 2 H), 1.24 (m, 2 H), 0.85 (t, J = 7.5 Hz, 3 H) ppm. 13C NMR
Eur. J. Org. Chem. 2011, 1755–1762
© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
1761